These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36213272)

  • 101. Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism.
    Li LR; Song JL; Liu HQ; Chen C
    Discov Oncol; 2023 Feb; 14(1):23. PubMed ID: 36811728
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The associations between thyroid-related hormones and the risk of thyroid cancer: An overall and dose-response meta-analysis.
    Wang Z; Lin Y; Jiang Y; Fu R; Wang Y; Zhang Q
    Front Endocrinol (Lausanne); 2022; 13():992566. PubMed ID: 36568112
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: A systematic review and meta-analysis.
    Hu X; Chen Y; Shen Y; Tian R; Sheng Y; Que H
    Front Public Health; 2022; 10():1020709. PubMed ID: 36311599
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis.
    Mellenthin C; Balaban VD; Dugic A; Cullati S
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230607
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Dietary phenolic compounds as promising therapeutic agents for diabetes and its complications: A comprehensive review.
    Aryal D; Joshi S; Thapa NK; Chaudhary P; Basaula S; Joshi U; Bhandari D; Rogers HM; Bhattarai S; Sharma KR; Regmi BP; Parajuli N
    Food Sci Nutr; 2024 May; 12(5):3025-3045. PubMed ID: 38726403
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Association between diabetes and subsequent malignancy risk among older breast cancer survivors.
    Hardell KNL; Schonfeld SJ; Ramin C; Vo JB; Morton LM
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38718185
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Correlation Between Glycemic Control and Serum Thyroglobulin Levels in a Patient With RAI-Refractory Thyroid Cancer.
    Hataya Y; Nomura T; Fujishima Y; Fujimoto K; Iwakura T; Matsuoka N
    JCEM Case Rep; 2024 May; 2(5):luae085. PubMed ID: 38707655
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Associations of Combined Exposure to Metabolic and Inflammatory Indicators with Thyroid Nodules in Adults: A Nested Case-Control Study.
    Zhu XY; Meng XC; Cheng BJ; Wang C; Wang J; Li TL; Li H; Meng K; Liu R
    Int J Endocrinol; 2024; 2024():3950894. PubMed ID: 38571926
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention.
    Wu R; Zhang J; Zou G; Li S; Wang J; Li X; Xu J
    Diabetes Metab Syndr Obes; 2024; 17():809-823. PubMed ID: 38380275
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Thyroid cancer and insulin resistance.
    Brenta G; Di Fermo F
    Rev Endocr Metab Disord; 2024 Feb; 25(1):19-34. PubMed ID: 37957487
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Association between diabetes at different diagnostic ages and risk of cancer incidence and mortality: a cohort study.
    Peng Y; Liu F; Wang P; Qiao Y; Si C; Wang X; Gong J; Zhou H; Song F; Song F
    Front Endocrinol (Lausanne); 2023; 14():1277935. PubMed ID: 37900125
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
    Tseng CH
    Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts.
    Thompson CA; Stürmer T
    Diabetes Care; 2023 Feb; 46(2):249-251. PubMed ID: 36525594
    [No Abstract]   [Full Text] [Related]  

  • 114. Diabetes mellitus and risk of thyroid cancer: a meta-analysis.
    Yeo Y; Ma SH; Hwang Y; Horn-Ross PL; Hsing A; Lee KE; Park YJ; Park DJ; Yoo KY; Park SK
    PLoS One; 2014; 9(6):e98135. PubMed ID: 24927125
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies.
    Li H; Qian J
    Medicine (Baltimore); 2017 Nov; 96(47):e8230. PubMed ID: 29381912
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.
    Fang H; Yao B; Yan Y; Xu H; Liu Y; Tang H; Zhou J; Cao L; Wang W; Zhang J; Zhao L; Chen X; Zhang F; Zhao Y
    Diabetes Technol Ther; 2013 Nov; 15(11):914-22. PubMed ID: 24180357
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis.
    Wang H; Ba Y; Xing Q; Du JL
    BMJ Open; 2019 Jan; 9(1):e024067. PubMed ID: 30610024
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Diabetes Mellitus Is Associated with a Lower Risk of Gout: A Meta-Analysis of Observational Studies.
    Li X; Li L; Xing Y; Cheng T; Ren S; Ma H
    J Diabetes Res; 2020; 2020():5470739. PubMed ID: 32733967
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Different types of diabetes mellitus and risk of thyroid cancer: A meta-analysis of cohort studies.
    Dong WW; Zhang DL; Wang ZH; Lv CZ; Zhang P; Zhang H
    Front Endocrinol (Lausanne); 2022; 13():971213. PubMed ID: 36213272
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.